Causal inference for long-term survival in randomised trials with treatment switching: Should re-censoring be applied when estimating counterfactual survival times?

Treatment switching often has a crucial impact on estimates of effectiveness and cost-effectiveness of new oncology treatments. Rank preserving structural failure time models (RPSFTM) and two-stage estimation (TSE) methods estimate ‘counterfactual’ (i.e. had there been no switching) survival times a...

Descripción completa

Detalles Bibliográficos
Autores principales: Latimer, NR, White, IR, Abrams, KR, Siebert, U
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676341/
https://www.ncbi.nlm.nih.gov/pubmed/29940824
http://dx.doi.org/10.1177/0962280218780856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676341/
https://www.ncbi.nlm.nih.gov/pubmed/29940824
http://dx.doi.org/10.1177/0962280218780856

Ejemplares similares